Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara ...
Based on these series of clinical trials, all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) as the front-line treatment has been adopted in all contemporary guidelines since 2013 (18–21). A ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Speaking at the office launch of Norrenberger Asset Management Limited and the 2025 capital market outlook event in Abuja on Monday, the SEC Director-General, Dr Emomotimi Agama, reaffirmed the ...
Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.
Airbus announced that, on Jan. 21, 2025, the A320 ATRA (Advanced Technology Research Aircraft) flew for the first time from the German Aerospace Center (DLR) in Braunschweig, Germany, after the ...
Airbus flew the ATRA flight test aircraft that has been modified for the Eurofighter electronically scanned (E-Scan) radar on 21 January. (Airbus) Airbus has flown the Advanced Technology Research ...
Price Action: ATRA stock is down 4.09% at $6.302 at last check Tuesday.
Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA. Jul 27, 2022 10:49am ET ATRA INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results